General Information of Drug Transporter (DT)
DT ID DTD0028 Transporter Info
Gene Name SLC47A2
Transporter Name Multidrug and toxin extrusion protein 2
Gene ID
146802
UniProt ID
Q86VL8
Epigenetic Regulations of This DT (EGR)

Histone acetylation

  Renal cell carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Hyperacetylation of SLC47A2 in renal cell carcinoma (compare with adjacent counterpart normal cells) [ 1 ]

Location

Promoter

Epigenetic Type

Histone acetylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC47A2 Experiment Method RT-qPCR

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patients samples of human

Additional Notes

H3K27AC might play a repressive role in the expression of SLC47A2 in RCC.

Histone trimethylation

  Renal cell carcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Lower level of histone trimethylation of SLC47A2 in renal cell carcinoma (compare with adjacent counterpart normal cells) [ 1 ]

Location

Promoter

Epigenetic Type

Histone trimethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC47A2 Experiment Method RT-qPCR

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patients samples of human

Additional Notes

H3K27me3 might play a repressive role in the expression of SLC47A2 in RCC.

  Epigenetic Phenomenon 2

Lower level of histone trimethylation of SLC47A2 in renal cell carcinoma (compare with adjacent counterpart normal cells) [ 1 ]

Location

Promoter

Epigenetic Type

Histone trimethylation Experiment Method Chromatin immunoprecipitation

Related Molecular Changes

Down regulation of SLC47A2 Experiment Method RT-qPCR

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patients samples of human

Additional Notes

H3K4me3 might play a repressive role in the expression of SLC47A2 in RCC.

lncRNA

  Renal cell carcinoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon 1

Lower expression of lncRNA-SANT1 downregulates SLC47A2 expression in renal cell carcinoma [ 2 ]

Epigenetic Type

lncRNA Experiment Method RT-qPCR

Related Molecular Changes

Down regulation of SLC47A2 Experiment Method Western Blot

Studied Phenotype

Renal cell carcinoma [ ICD-11: 2C90]

Experimental Material

Patients samples of human; Multiple cell lines of human

Additional Notes

Low SANT1 expression increased E2F1/HDAC1 binding to the entire coding gene promoter, which induced a significantly lower level of histone H3K27ac modification.

Methylation

References
1 Histone H3 Lysine 4 Trimethylation, Lysine 27 Trimethylation, and Lysine 27 Acetylation Contribute to the Transcriptional Repression of Solute Carrier Family 47 Member 2 in Renal Cell Carcinoma. Drug Metab Dispos. 2017 Jan;45(1):109-117.
2 A novel human lncRNA SANT1 cis-regulates the expression of SLC47A2 by altering SFPQ/E2F1/HDAC1 binding to the promoter region in renal cell carcinoma. RNA Biol. 2019 Jul;16(7):940-949.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.